MARCUS NARTEY: Open Payments
NPI 1205187580 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 43 payments from 21 companies in 2025. Trend: 2023 $4,484 · 2024 $2,752 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 5 | $289 |
| ABBVIE INC. | 6 | $134 |
| PFIZER INC. | 4 | $94 |
| Eisai Inc. | 3 | $83 |
| UCB, Inc. | 3 | $82 |
| Orthofix Medical, Inc. | 1 | $69 |
| ACADIA Pharmaceuticals Inc | 3 | $66 |
| Averitas Pharma Inc. | 2 | $46 |
| Amneal Pharmaceuticals LLC | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
Products named: Leqembi, QULIPTA, Nayzilam, SABLE, Cervical-Stim, NUPLAZID, QUARTEX, XLIF.
Industry payments across PA — which companies pay providers there.
